Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation.
OBJECTIVE
To evaluate the protective effect of WR-151327 on late radiation-induced damage to normal tissues in mice.


METHODS
The right hind legs of mice with or without WR-151327 administration (400 mg/kg) were irradiated with 137Cs gamma rays. Leg contracture and skin shrinkage assays were performed at 380 days after irradiation. The mice were killed on day 400 postirradiation and histological sections of the legs were made. The thickness of the dermis, epidermis, and skin (dermis plus epidermis) was measured. The muscular area of the legs and the posterior knee angle between the femur and tibia were also measured. The left hind legs were similarly assessed as nonirradiated controls. Group means and standard deviations were calculated and dose-response curves were drawn for every endpoint. Then, the dose modifying factor (DMF) for each endpoint and the correlations among endpoints were determined.


RESULTS
Late damage assayed by leg contracture and skin shrinkage progressed with increasing radiation dose. However, it was reduced by drug treatment. The significant effect was indicated for skin shrinkage by a DMF of 1.8 at 35%. The DMF for leg contracture was 1.3 at 6 mm. In the irradiated legs, epidermal hyperplasia and dermal fibrosis in the skin, muscular atrophy, and extension disturbance of the knee joint were observed. These changes progressed with increasing radiation dose. Skin damage assayed by the present endpoints was also reduced by drug treatment by DMFs of 1.4 to 1.7. However, DMFs for damage to the muscle and knee were not determined because no isoeffect was observed. There were good correlations between leg contracture or skin shrinkage and the other endpoints in both untreated and drug-treated mice.


CONCLUSIONS
WR-151327 has the potential to protect against radiation-induced late normal tissue damage.
Section of Laboratory Animals, National Institute of Radiological Sciences, Chiba, Japan.
S
S
Matsushita
K
K
Ando
S
S
Koike
D J
DJ
Grdina
S
S
Furukawa
D000818:Animals; D004817:Epidermis / Q000033:anatomy & histology / Q000528:radiation effects; D005260:Female; D005720:Gamma Rays / Q000009:adverse effects*; D006614:Hindlimb / Q000528:radiation effects*; D051379:Mice; D008809:Mice, Inbred C3H; D009119:Muscle Contraction / Q000528:radiation effects; D018482:Muscle, Skeletal / Q000528:radiation effects; D009133:Muscular Atrophy / Q000209:etiology / Q000517:prevention & control; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D012867:Skin / Q000033:anatomy & histology / Q000528:radiation effects
D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; C048392:WR 151327